CuraScientific Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, sales was USD 0.822127 million compared to USD 0.034434 million a year ago. Net income was USD 41.07 million compared to net loss of USD 3.8 million a year ago. Basic earnings per share from continuing operations was USD 0.39 compared to basic loss per share from continuing operations of USD 0.77 a year ago. Diluted earnings per share from continuing operations was USD 0.28 compared to diluted loss per share from continuing operations of USD 0.77 a year ago.